A Placebo-controlled Study With an Extension Examining the Safety and Efficacy of Alefacept in Psoriatic Arthritis
Status:
Completed
Trial end date:
2005-03-01
Target enrollment:
Participant gender:
Summary
Randomized, double-blind, 24-week study of patients with psoriatic arthritis comparing
alefacept + methotrexate (MTX) vs. placebo + MTX followed by a 24-week open-label extension
with only alefacept + MTX treatment.